B. Metzler seel. Sohn & Co. Holding AG Makes New Investment in The Cooper Companies, Inc. (NASDAQ:COO)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 10,456 shares of the medical device company’s stock, valued at approximately $1,154,000.

Other large investors have also bought and sold shares of the company. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies during the third quarter valued at approximately $25,000. Covestor Ltd raised its holdings in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 208 shares during the last quarter. Innealta Capital LLC purchased a new position in shares of Cooper Companies during the second quarter valued at approximately $25,000. Crewe Advisors LLC raised its holdings in shares of Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after purchasing an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC raised its holdings in shares of Cooper Companies by 75.4% during the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after purchasing an additional 169 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday. Robert W. Baird boosted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Morgan Stanley boosted their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Performance

COO opened at $100.80 on Friday. The firm has a market cap of $20.07 billion, a P/E ratio of 56.00, a PEG ratio of 2.15 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38. The company has a 50 day simple moving average of $105.91 and a two-hundred day simple moving average of $98.29. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the prior year, the business earned $0.84 earnings per share. Cooper Companies’s revenue for the quarter was up 7.8% on a year-over-year basis. Equities analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.